# Acamprosate Calcium

NDC: 68462-435
Generic name: Acamprosate Calcium
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20130716

FDA application: ANDA202229

## Active ingredients

- ACAMPROSATE CALCIUM: 333 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-435"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-435
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43e9ef60-2d85-4394-906b-93042fea099a